EIF4G1 antibody

Cat.#: 110263

Size:

Special Price 239.0 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    EIF4G1 antibody
  • Documents
  • Description
    EIF4G1 Rabbit Polyclonal antibody. Positive WB detected in HeLa cells. Positive IP detected in HeLa cells. Positive IF detected in Hela cells, Ethacrynic acid treated HepG2 cells, HepG2 cells. Positive IHC detected in human breast cancer tissue. Observed molecular weight by Western-blot: 250 kDa
  • Tested applications
    ELISA, WB, IHC, IF, IP
  • Species reactivity
    Human,Mouse,Rat; other species not tested.
  • Alternative names
    DKFZp686A1451 antibody; eIF 4 gamma 1 antibody; eIF 4G 1 antibody; eIF 4G1 antibody; EIF4F antibody; EIF4G antibody; EIF4G1 antibody; EIF4GI antibody; p220 antibody
  • Isotype
    Rabbit IgG
  • Preparation
    This antibody was obtained by immunization of EIF4G1 recombinant protein (Accession Number: BC007788). Purification method: Antigen affinity purified.
  • Clonality
    Polyclonal
  • Formulation
    PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
  • Storage instructions
    Store at -20℃. DO NOT ALIQUOT
  • Applications

    Recommended Dilution:

    WB: 1:500-1:5000

    IP: 1:200-1:2000

    IHC: 1:20-1:200

    IF: 1:10-1:100

  • Validations

    HeLa cells were subjected to SDS PAGE followed by western blot with Catalog No:110263(EIF4G1 antibody) at dilution of 1:1000

    HeLa cells were subjected to SDS PAGE followed by western blot with Catalog No:110263(EIF4G1 antibody) at dilution of 1:1000

    Immunohistochemical of paraffin-embedded human breast cancer using Catalog No:110263(EIF4G1 antibody) at dilution of 1:100 (under 40x lens)

    Immunohistochemical of paraffin-embedded human breast cancer using Catalog No:110263(EIF4G1 antibody) at dilution of 1:100 (under 40x lens)

    Immunofluorescent analysis of Hela cells, using EIF4G1 antibody Catalog No:110263 at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).

    Immunofluorescent analysis of Hela cells, using EIF4G1 antibody Catalog No:110263 at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).

    IP Result of anti-EIF4G1 (IP:Catalog No:110263, 5ug; Detection:Catalog No:110263 1:500) with HeLa cells lysate 2000ug.

    IP Result of anti-EIF4G1 (IP:Catalog No:110263, 5ug; Detection:Catalog No:110263 1:500) with HeLa cells lysate 2000ug.

  • Background
    Eukaryotic cellular messenger RNAs are posttranscriptionally modified by addition of an m(7)GTP moiety to the 5-prime terminus, referred to as a cap. Recognition of the cap structure and unwinding of mRNA secondary structure during the initiation phase of protein synthesis is catalyzed by initiation factors of the eIF4 group. EIF4G1, a subunit of eIF4 gamma, forms various complexes with the other eIF4 polypeptides [PMID: 7601469]. Mutations in the EIF4G1 gene, encoding a component of the eIF4F translation initiation complex, were recently reported as a possible cause for the autosomal dominant form of Parkinson's disease [PMID:22658323].
  • References
    • Wu S, Wang Y, Lin L. Protease 2A induces stress granule formation during coxsackievirus B3 and enterovirus 71 infections. Virology journal. 11:192. 2014.
    • Hu S, Li J, Xu F. SAMHD1 Inhibits LINE-1 Retrotransposition by Promoting Stress Granule Formation. PLoS genetics. 11(7):e1005367. 2015.
    • Wehbe M, Huguenin A, Leveque N. Construction of a subgenomic CV-B3 replicon expressing emerald green fluorescent protein to assess viral replication of a cardiotropic enterovirus strain in cultured human cells. Journal of virological methods. 230:1-8. 2016.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"